NCT04671511View on ClinicalTrials.gov

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Breast Cancer FemaleEarly-stage Breast CancerLymph Node MetastasesAxillary MetastasesSentinel Lymph Node
Interventions
PROCEDURE

Targeted Axillary Dissection

Sentinel Node Biopsy (SNB; using Tc99 +/- Blue dye) + Radioactive Seed Localisation (RSL) of clipped node using I125 seed = Targeted Axillary Dissection (TAD)

DIAGNOSTIC_TEST

Ultrasound of the axilla

Prospectively recorded preoperative ultrasound of the axilla. Number of suspicious nodes recorded. Biopsy and clipping of the positive node.

Trial Locations (3)

H1T2M4

RECRUITING

Hôpital Maisonneuve-Rosemont, Montreal

H2X 3E4

RECRUITING

Centre hospitalier de l'Université de Montréal, Montreal

H3T 1E2

RECRUITING

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

Quebec Breast Cancer Foundation

OTHER

lead

Jewish General Hospital

OTHER